Week in Review: June 3–7

Crowdsourcing biomedical research; bird flu contagion?; zebrafish shed light on inherited muscle disorder; the economics of the Human Genome Project; the epigenetics of pair bonding

Written byJef Akst
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

WIKIMEDIA, W.REBELSeveral open-source biomedical challenges are pitting groups of researchers against each other in the name of science. The Big Data computational challenges, for example, hosted by Sage Bionetworks and DREAM (Dialogue for Reverse Engineering Assessments and Methods), are sharing genomic and clinical data, from which researchers are devising models to predict outcome and survival. The models, which are also shared among challenge contestants, are then vetted against real-life survival data and scored based on the accuracy of their predictions.

“A tsunami of omics data have shown us that many diseases we thought were quite simple are increasingly complex with multiple sub-types,” Sage-cofounder Stephen Friend told The Scientist. “Meshing these data with clinical outcomes to develop predictors of who is likely to respond to therapy or who is likely to have aggressive disease is an audaciously large problem that necessitates working off of each other's insights. This just simply cannot be done by one lone scientist.”

WIKIPEDIA, M EICKMANNStructural analyses of current strains of H5N1 and H7N9 avian influenza suggest that just one mutation could be enough to render the viruses transmissible between humans. Though there have been no definitive cases of human-to-human transmission yet, the deadly nature of infections acquired from birds has many fearing a possible pandemic. Understanding how the viruses might evolve to become contagious should help public health officials prepare for such an outbreak.

“These viruses are rapidly evolving and our stockpiles of vaccine are largely based on outdated strains,” said Ram Sasisekharan of the Massachusetts Institute of ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • Jef (an unusual nickname for Jennifer) got her master’s degree from Indiana University in April 2009 studying the mating behavior of seahorses. After four years of diving off the Gulf Coast of Tampa and performing behavioral experiments at the Tennessee Aquarium in Chattanooga, she left research to pursue a career in science writing. As The Scientist's managing editor, Jef edited features and oversaw the production of the TS Digest and quarterly print magazine. In 2022, her feature on uterus transplantation earned first place in the trade category of the Awards for Excellence in Health Care Journalism. She is a member of the National Association of Science Writers.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies